This review outlines priorities and open questions in HTLV research: Review the global prevalence of HTLV-1 infection and identify opportunities and means to expand epidemiological studies. Identify biomarkers to predict disease progression. Develop prophylactic and therapeutic vaccines. Screen for existing and novel drugs to improve therapy. Perform basic research to unravel mechanisms of pathogenesis and open insights into novel treatments.